Lynch Syndrome Is a Common Hereditary Condition That Can Cause Ovarian Cancer—So Why Isn’t Anybody Talking About It?
by NELL CASEY, Vogue.com It’s hard to recall a time before BRCA. In the two decades since testing for the two gene mutations—BRCA1 and BRCA2—linked to breast and ovarian cancers became available, tens of thousands of women whose results came back positive have elected to undergo prophylactic surgery, giving rise to the term previvors. Following […]
Read More
Protein Discovery Brings Hope of Early Detection for Ovarian Cancer
Hopes of finding an early-warning signal for ovarian cancer have been boosted by a protein discovery at the Hunter Medical Research Institute (HMRI). A research team from the University of Newcastle and Hunter New England Health, comprising cancer scientists, oncologists, gynaecologists and geneticists, spent three years investigating the earliest lesions involved in the disease with […]
Read More
This FDA News Could Totally Shake Up The Beauty Industry
By Emily Rekstis | May 13, 2017 | NewBeauty.com It’s a little well-known fact in the beauty world that the FDA doesn’t have the strictest of regulations when it comes to monitoring beauty products. However, there are now two senators who are looking to change that. Senators Dianne Feinstein and Susan Collins proposed the Personal […]
Read More
Unexpected presence of glucose receptor in ovarian cancer links metabolism to most aggressive cases
A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue level. GLUT1 is a receptor protein involved in the absorption of glucose, or sugar, in the bloodstream and across membranes in the body. Physiologically, […]
Read More
Combination therapy could provide new treatment option for ovarian cancer
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin. Preclinical research from Dr. Sanaz Memarzadeh, who is a member of the Eli and Edythe Broad Center of […]
Read More
Women should continue cervical cancer screening as they approach age 65
Adjusted rates for cervical cancer do not decline until age 85, signaling a need for ongoing surveillance, according to a new study Cervical cancer is often thought of as a disease that primarily affects young women. Because of this, many older women fail to keep up with appropriate screening as they age. While current guidelines […]
Read More
Ovarian Cancer and Genetics
Written by Yolanda Smith, BPharm Women who have a strong family history of breast or ovarian cancer are more likely to be affected by cancer of the ovaries, fallopian tube, or peritoneal cavity. This is thought to be due to a mutation in one of the genes that are involved in the regulation of cell […]
Read More
Teen model Peyton Linafelter describes her battle with stage 4 ovarian cancer
By Stephanie Nolasco | Published April 04, 2017 | FoxNews.com At age 15, Peyton Linafelter was having one of the best years of her life. The Colorado native was just learning to drive and had the chance to see Taylor Swift in concert where she was scouted by an agent to become a model. But […]
Read More
Weight Loss Tied to Lower Risk of Uterine Cancer
By Robert Preidt (HealthDay Reporter) Benefit was greatest in women who were obese and achieved a normal weight, study suggests THURSDAY, Feb. 2, 2017 (HealthDay News) — Weight loss may lower older women’s risk of cancer of the endometrium, the lining of the uterus, a new study suggests. “Many older adults think it’s too late […]
Read More